Foghorn Retained Earnings from 2010 to 2024

FHTX Stock

USD 7.90 0.06 0.77%

Foghorn Therapeutics Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that Foghorn Therapeutics retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2019-09-30

Previous Quarter

-519.6 M

Current Value

-538.7 M

Quarterly Volatility

149.7 M

Covid

Check Foghorn Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Foghorn Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 11.1 M, Interest Income of 11.1 M or Depreciation And Amortization of 3.9 M, as well as many indicators such as Price To Sales Ratio of 7.53, Dividend Yield of 0.0 or Days Sales Outstanding of 66.4 K. Foghorn financial statements analysis is a perfect complement when working with Foghorn Therapeutics Valuation or Volatility modules.

Check out the analysis of Foghorn Therapeutics Correlation against competitors.

For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn Therapeutics guide.

Latest Foghorn Therapeutics' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Foghorn Therapeutics over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Foghorn Therapeutics' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Foghorn Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (471.56 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Foghorn Retained Earnings Regression Statistics

	Arithmetic Mean	(146,739,187)
	Coefficient Of Variation	(109.46)
	Mean Deviation	131,491,182
	Median	(43,008,000)
	Standard Deviation	160,623,377
	Sample Variance	25799.9T
	Range	428.6M
	R-Value	(0.84)
	Mean Square Error	8382T
	R-Squared	0.70
	Significance	0.0001
	Slope	(30,013,795)
	Total Sum of Squares	361198.2T

Foghorn Retained Earnings History

	2024	-448 M
	2023	-471.6 M
	2022	-373.1 M
	2021	-264.3 M
	2020	-162.9 M
	2019	-94.1 M

Other Fundumenentals of Foghorn Therapeutics

Retained Earnings Total Equity

Foghorn Therapeutics Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Current Deferred Revenue	Short Long Term Debt	Short Term Debt	Net Receivables	Short Term Investments	Capital Surpluse
Total Assets		0.55	0.73	-0.48	-0.8	0.78	0.89	0.93	0.49	1.0	0.99	0.92	0.91	0.54	-0.33	0.87	0.65	0.43	0.73
Total Stockholder Equity	0.55		0.91	-0.09	-0.06	0.1	0.47	0.23	1.0	0.52	0.57	0.48	0.59	0.1	0.31	0.18	0.53	-0.14	-0.08
Net Tangible Assets	0.73	0.91		-0.06	-0.41	0.41	0.71	0.46	0.89	0.7	0.73	0.75	0.83	0.11	-0.09	0.51	0.51	0.0	0.28
Net Debt	-0.48	-0.09	-0.06		0.41	-0.45	-0.36	-0.55	-0.05	-0.48	-0.48	-0.38	-0.33	-0.99	-0.06	-0.33	0.02	-0.88	-0.37
Retained Earnings	-0.8	-0.06	-0.41	0.41		-0.95	-0.84	-0.88	-0.01	-0.79	-0.75	-0.89	-0.83	-0.51	0.74	-0.95	-0.21	-0.64	-0.96
Accounts Payable	0.78	0.1	0.41	-0.45	-0.95		0.92	0.86	0.07	0.76	0.71	0.9	0.85	0.56	-0.55	0.91	0.16	0.66	0.91
Long Term Debt	0.89	0.47	0.71	-0.36	-0.84	0.92		0.85	0.44	0.86	0.84	0.98	0.97	0.47	-0.34	0.89	0.39	0.46	0.78
Total Liab	0.93	0.23	0.46	-0.55	-0.88	0.86	0.85		0.16	0.94	0.92	0.86	0.81	0.62	-0.41	0.94	0.56	0.56	0.88
Net Invested Capital	0.49	1.0	0.89	-0.05	-0.01	0.07	0.44	0.16		0.47	0.51	0.44	0.55	0.06	0.34	0.12	0.48	-0.17	-0.13
Total Current Assets	1.0	0.52	0.7	-0.48	-0.79	0.76	0.86	0.94	0.47		1.0	0.9	0.89	0.54	-0.32	0.87	0.68	0.42	0.73
Net Working Capital	0.99	0.57	0.73	-0.48	-0.75	0.71	0.84	0.92	0.51	1.0		0.87	0.87	0.53	-0.28	0.83	0.71	0.39	0.68
Common Stock	0.92	0.48	0.75	-0.38	-0.89	0.9	0.98	0.86	0.44	0.9	0.87		0.99	0.47	-0.45	0.91	0.38	0.49	0.82
Property Plant Equipment	0.91	0.59	0.83	-0.33	-0.83	0.85	0.97	0.81	0.55	0.89	0.87	0.99		0.43	-0.39	0.86	0.42	0.42	0.73
Current Deferred Revenue	0.54	0.1	0.11	-0.99	-0.51	0.56	0.47	0.62	0.06	0.54	0.53	0.47	0.43		-0.01	0.41	0.0	0.91	0.45
Short Long Term Debt	-0.33	0.31	-0.09	-0.06	0.74	-0.55	-0.34	-0.41	0.34	-0.32	-0.28	-0.45	-0.39	-0.01		-0.59	0.09	-0.32	-0.68
Short Term Debt	0.87	0.18	0.51	-0.33	-0.95	0.91	0.89	0.94	0.12	0.87	0.83	0.91	0.86	0.41	-0.59		0.44	0.47	0.96
Net Receivables	0.65	0.53	0.51	0.02	-0.21	0.16	0.39	0.56	0.48	0.68	0.71	0.38	0.42	0.0	0.09	0.44		-0.28	0.22
Short Term Investments	0.43	-0.14	0.0	-0.88	-0.64	0.66	0.46	0.56	-0.17	0.42	0.39	0.49	0.42	0.91	-0.32	0.47	-0.28		0.58
Capital Surpluse	0.73	-0.08	0.28	-0.37	-0.96	0.91	0.78	0.88	-0.13	0.73	0.68	0.82	0.73	0.45	-0.68	0.96	0.22	0.58

Click cells to compare fundamentals

About Foghorn Therapeutics Financial Statements

Foghorn Therapeutics investors use historical fundamental indicators, such as Foghorn Therapeutics' Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Foghorn Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Retained Earnings	-471.6 M	-448 M
Retained Earnings Total Equity	-335.8 M	-352.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Foghorn Stock Analysis

When running Foghorn Therapeutics' price analysis, check to measure Foghorn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn Therapeutics is operating at the current time. Most of Foghorn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Foghorn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn Therapeutics' price. Additionally, you may evaluate how the addition of Foghorn Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC